These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37516380)

  • 21. Clinical Impact of Intravascular Ultrasound-Guided Fluoropolymer-Based Drug-Eluting Stent Implantation for Femoropopliteal Lesions.
    Tsujimura T; Iida O; Takahara M; Soga Y; Yamaoka T; Fujihara M; Kawasaki D; Ichihashi S; Kozuki A; Nanto S; Sakata Y; Mano T;
    JACC Cardiovasc Interv; 2022 Aug; 15(15):1569-1578. PubMed ID: 35926923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
    Buszman PP; Milewski K; Pająk J; Jelonek M; Orlik B; Krauze A; Gwiazdowska-Nowotka B; Wojakowski W; Tellez A; Granada JF; Buszman PE
    EuroIntervention; 2014 Oct; 10(6):724-31. PubMed ID: 24469344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents.
    Torii S; Cheng Q; Mori H; Lipinski MJ; Acampado E; Perkins LEL; Hossainy SF; Pacetti SD; Kolodgie FD; Virmani R; Finn AV
    EuroIntervention; 2019 Mar; 14(16):1685-1693. PubMed ID: 29619983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Year All-Comers Analysis of the Eluvia Drug-Eluting Stent for Long Femoropopliteal Lesions After Suboptimal Angioplasty.
    Bisdas T; Beropoulis E; Argyriou A; Torsello G; Stavroulakis K
    JACC Cardiovasc Interv; 2018 May; 11(10):957-966. PubMed ID: 29798772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological effect on restenosis and vascular healing of encapsulated paclitaxel nanocrystals delivered via coated balloon technology in the familial hypercholesterolaemic swine model of in-stent restenosis.
    Cheng Y; Shibuya M; McGregor J; Conditt GB; Yi GH; Kaluza GL; Gray W; Doshi M; Sojitra P; Granada JF
    EuroIntervention; 2016 Oct; 12(9):1164-1173. PubMed ID: 27753601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year clinical outcomes and predictors of restenosis following the use of polymer-coated paclitaxel-eluting stents or drug-coated balloons in patients with femoropopliteal artery disease.
    Yoshioka N; Tokuda T; Koyama A; Yamada T; Shimamura K; Nishikawa R; Morita Y; Morishima I;
    Heart Vessels; 2023 Mar; 38(3):429-437. PubMed ID: 36169709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular Response After FP-PES Versus Polymer-Free Paclitaxel-Eluting Stent Implantation in Femoropopliteal Artery Lesions: A Serial Intravascular Ultrasound Study.
    Tomoi Y; Kuramitsu S; Soga Y; Fujihara M; Iida O; Kawasaki D; Ando K
    JACC Cardiovasc Interv; 2020 Feb; 13(4):535-537. PubMed ID: 32081246
    [No Abstract]   [Full Text] [Related]  

  • 29. Propensity Score Analysis Comparing Clinical Outcomes of Drug-Eluting vs Bare Nitinol Stents in Femoropopliteal Lesions.
    Soga Y; Takahara M; Iida O; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Ando K
    J Endovasc Ther; 2016 Feb; 23(1):33-9. PubMed ID: 26763256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Tibial Runoff on Outcomes of Endovascular Treatment for Femoropopliteal Atherosclerotic Lesions.
    Park UJ; Kim HT; Roh YN
    Vasc Endovascular Surg; 2018 Oct; 52(7):498-504. PubMed ID: 29852805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioabsorbable Drug-Eluting Stent Versus Bare Metal Stent in Iliac Artery Evaluated by Optical Coherence Tomography: An In Vivo Study in Porcine.
    Zhao Y; Chen Z; Zhang WW; Wang S; Yang Y; Yang L
    Vasc Endovascular Surg; 2018 Oct; 52(7):512-519. PubMed ID: 30012078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
    Jabara R; Chronos N; Conway D; Molema W; Robinson K
    JACC Cardiovasc Interv; 2008 Feb; 1(1):81-7. PubMed ID: 19393150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
    Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
    Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.
    Shinke T; Geva S; Pendyala L; Jabara R; Li J; Chen JP; Venegoni A; Colley K; Klein R; Chronos N; Robinson K; Hou D
    Int J Cardiol; 2009 Jun; 135(1):93-101. PubMed ID: 18692915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.
    Waksman R; Pakala R; Baffour R; Seabron R; Hellinga D; Chan R; Su SH; Kolodgie F; Virmani R
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):429-36. PubMed ID: 22105925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the vascular response in implantation of self-expanding, bare metal nitinol stents or paclitaxel-eluting nitinol stents in superficial femoral artery lesions: a serial optical frequency domain imaging study.
    Miki K; Fujii K; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Nishimura M; Horimatsu T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    EuroIntervention; 2016 Dec; 12(12):1551-1558. PubMed ID: 27998849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.
    Sheehy A; Hsu S; Bouchard A; Lema P; Savard C; Guy LG; Tai J; Polyakov I
    Cardiovasc Diabetol; 2012 Jun; 11():75. PubMed ID: 22716997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Quantitative Angiographic Comparison of Restenotic Tissue Following Placement of Drug-Eluting Stents and Bare Metal Stents in Symptomatic Patients With Femoropopliteal Disease.
    Ansel GM; Jaff MR; Popma JJ; Battisti AJ; Lottes AE; Harnish P; Dake MD
    J Endovasc Ther; 2017 Aug; 24(4):499-503. PubMed ID: 28485182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis.
    Iida O; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1105-1112. PubMed ID: 26117463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stents coated with sirolimus and anti-CD34 antibody can optimize the performance of sirolimus-eluting stents].
    Song XT; Zhu HG; Yang XS; Yuan F; Lü SZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Nov; 39(11):997-1004. PubMed ID: 22336451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.